A mathematical model for reconstitution of granulopoiesis after high dose chemotherapy with autologous stem cell transplantation

被引:32
|
作者
Ostby, I [1 ]
Rusten, LS
Kvalheim, G
Grottum, P
机构
[1] Univ Oslo, Dept Informat, N-0316 Oslo, Norway
[2] Norwegian Radium Hosp, Stem Cell Lab, N-0310 Oslo, Norway
关键词
granulopoiesis; mathematical model; high dose chemotherapy; stem cell support; engraftment time; CFU-GM cells; CD34+cells;
D O I
10.1007/s00285-003-0198-6
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
High dose chemotherapy supported with hematopoietic progenitor cells gives a characteristic neutropenic period (blood neutrophils <0.5.10(9) c/l) ranging from 10 to 16 days. The question of a correlation between the CFU-GM content of the transplanted CD34+ cells and time to neutrophil recovery by patients having been given high-dose chemotherapy (HD-CT) with stem cell support was addressed by means of a mathematical model of granulopoiesis. The model utilizes a convection-reaction partial differential equation (PDE) with feedback from a cytokine compartment on proliferation, maturation, and mobilization of granulocytes from bone marrow to blood. The observed number of CFU-GM cells in the transplanted CD34+ cell autograft was used as input to the model. Using this approach, the observed gross relationship between CFU-GM content in the reinfused blood product and engraftment time could be reproduced. At the same time, the effects of assumed physiological mechanisms, especially some of the effects of G-CSF on proliferation rate, maturation rate, mobilization, and cell death, could be investigated and discussed relative to observed engraftment. The model makes it possible to explain how cytokines interfere with progenitor cell mobilization from bone marrow to blood, and it points out the implications of a regulating mechanism for the granulocyte maturation rate.
引用
收藏
页码:101 / 136
页数:36
相关论文
共 50 条
  • [21] Aerobic exercise in the rehabilitation of cancer patients after high dose chemotherapy and autologous peripheral stem cell transplantation
    Dimeo, FC
    Tilmann, MHM
    Bertz, H
    Kanz, L
    Mertelsmann, R
    Keul, J
    CANCER, 1997, 79 (09) : 1717 - 1722
  • [22] Infections after high-dose chemotherapy and autologous stem cell transplantation: results of a retrospective cohort study
    Abas, J.
    Bojko, P.
    Schiel, X.
    Schulz, S.
    Karthaus, M.
    Hentrich, M.
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 2) : 250 - 250
  • [23] Role of high dose chemotherapy and autologous hematopoietic stem cell transplantation in Hodgkin lymphoma
    不详
    ONCOLOGY IN CLINICAL PRACTICE, 2008, 4 : A1 - A22
  • [24] The potential of amifostine in high-dose chemotherapy and autologous hematopoietic stem cell transplantation
    Phillips, GL
    SEMINARS IN ONCOLOGY, 2002, 29 (06) : 53 - 56
  • [25] Trichoderma species fungemia after high-dose chemotherapy and autologous stem cell transplantation: a case report
    Festuccia, M.
    Giaccone, L.
    Gay, F.
    Brunello, L.
    Maffini, E.
    Ferrando, F.
    Talamo, E.
    Boccadoro, M.
    Serra, R.
    Barbui, A.
    Bruno, B.
    TRANSPLANT INFECTIOUS DISEASE, 2014, 16 (04) : 653 - 657
  • [26] High-dose chemotherapy and autologous stem cell transplantation in treating paediatric malignancies
    Valteau-Couanet, D.
    Dufour, C.
    Hartmann, O.
    ONCOLOGIE, 2007, 9 (12) : 827 - 831
  • [27] High-dose chemotherapy and autologous stem-cell transplantation in breast cancer
    Kier, P
    Ruckser, R
    Buxhofer, V
    Habertheuer, K
    Zelenka, P
    Tatzreiter, G
    Hübl, G
    Kittl, E
    Hauser, A
    Sebesta, C
    Hinterberger, W
    ACTA MEDICA AUSTRIACA, 2000, 27 : 33 - 36
  • [28] High-dose chemotherapy and autologous stem cell transplantation for pediatric brain tumors
    Lee, Soo Hyun
    Sung, Ki Woong
    JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2012, 55 (05): : 430 - 437
  • [29] High Dose Chemotherapy and Autologous Stem Cell Transplantation for Metastatic Breast Cancer: Is there a Place?
    Edward A. Stadtmauer
    Breast Cancer Research and Treatment, 2003, 81 (Suppl 1) : 111 - 115
  • [30] How to manage poor mobilizers for high dose chemotherapy and autologous stem cell transplantation?
    Atilla, Pinar Ataca
    Ozturk, Sule Mine Bakanay
    Demirer, Taner
    TRANSFUSION AND APHERESIS SCIENCE, 2017, 56 (02) : 190 - 198